Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-021851
Filing Date
2025-02-06
Accepted
2025-02-06 16:59:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d485087d424b5.htm 424B5 407083
2 GRAPHIC g485087g03k03.jpg GRAPHIC 42239
3 GRAPHIC g485087g28o28.jpg GRAPHIC 34465
4 GRAPHIC g485087g77j83.jpg GRAPHIC 28097
  Complete submission text file 0001193125-25-021851.txt   552967
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-280918 | Film No.: 25598222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)